Sugammadex dosing in bariatric patients

Anesthesiology

Volumn 118, Issue 3, 2013, Pages 754-

  Schmartz, Denis ^a   Guerci, Philippe ^a   Fuchs Buder, Thomas ^a  

^a CHU NANCY BRABOIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ROCURONIUM; SUGAMMADEX; SUXAMETHONIUM;

ANESTHESIA INDUCTION; BARIATRIC SURGERY; BODY WEIGHT; DRUG DOSE REGIMEN; DRUG SAFETY; GOOD CLINICAL PRACTICE; HUMAN; LETTER; NEUROMUSCULAR BLOCKING; PRIORITY JOURNAL; RISK FACTOR; STIMULUS RESPONSE;

BARIATRIC SURGERY; GAMMA-CYCLODEXTRINS; HUMANS; IDEAL BODY WEIGHT; LAPAROSCOPY; NEUROMUSCULAR BLOCKADE;

EID: 84874600412     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e31827bd335     Document Type: Letter

References (4)

1. Llauradó S, Sabaté A, Ferreres E, Camprubí I, Cabrera A: Sugammadex ideal body weight dose adjusted by level of neuromuscular blockade in laparoscopic bariatric surgery. Anesthesiology 2012; 117:93-8
2. Fuchs-Buder T, Claudius C, Skovgaard LT, Eriksson LI, Mirakhur RK, Viby-Mogensen J; 8th International Neuromuscular Meeting: Good clinical research practice in pharmacodynamic studies of neuromuscular blocking agents II: The Stockholm revision. Acta Anaesthesiol Scand 2007; 51:789-808
3. Blobner M, Eriksson LI, Scholz J, Motsch J, Della Rocca G, Prins ME: Reversal of rocuronium-induced neuromuscular blockade with sugammadex compared with neostigmine during sevoflurane anaesthesia: Results of a randomised, controlled trial. Eur J Anaesthesiol 2010; 27:874-81
4. Mirakhur RK: Sugammadex in clinical practice. Anaesthesia 2009; 64(Suppl 1): 45-54